The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Related articles in The JI
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Appel, H.
Right arrow Articles by Sieper, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Appel, H.
Right arrow Articles by Sieper, J.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CYSTEINE
*L-SERINE
The Journal of Immunology, 2004, 173: 6564-6573.
Copyright © 2004 by The American Association of Immunologists

The Solvent-Inaccessible Cys67 Residue of HLA-B27 Contributes to T Cell Recognition of HLA-B27/Peptide Complexes1

Heiner Appel2,3,*, Wolfgang Kuon3,*, Maren Kuhne*, Martin Hülsmeyer{dagger}, Simon Kollnberger§, Stefanie Kuhlmann*, Elisabeth Weiss, Martin Zeitz*, Kai Wucherpfennig||, Paul Bowness§ and Joachim Sieper*,{ddagger}

* Division of Gastroenterology, Infectiology and Rheumatology, Charité Berlin, Campus Benjamin Franklin, {dagger} Institute for Chemistry/Crystallography, Free University Berlin, and {ddagger} Deutsches Rheumaforschungszentrum Berlin, Berlin, Germany; § Medical Research Council Human Immunology Unit, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, United Kingdom; Institute for Anthropology and Human Genetics, Ludwig-Maximillians-Universität Munich, Munich, Germany; and || Department of Cancer Immunology and AIDS, Dana Farber Cancer Institute and Department of Neurology, Harvard Medical School, Boston, MA 02115

Crystallographic studies have suggested that the cysteine at position 67 (Cys67) in the B pocket of the MHC molecule HLA-B*2705 is of importance for peptide binding, and biophysical studies have documented altered thermodynamic stability of the molecule when Cys67 was mutated to serine (Ser67). In this study, we used HLA-B27.Cys67 and HLA-B27.Ser67 tetramers with defined T cell epitopes to determine the contribution of this polymorphic, solvent-inaccessible MHC residue to T cell recognition. We generated these HLA-B27 tetramers using immunodominant viral peptides with high binding affinity to HLA-B27 and cartilage-derived peptides with lower affinity. We demonstrate that the yield of refolding of HLA-B27.Ser67 molecules was higher than for HLA-B27.Cys67 molecules and strongly dependent on the affinity of the peptide. T cell recognition did not differ between HLA-B27.Cys67 and HLA.B27.Ser67 tetramers for the viral peptides that were investigated. However, an aggrecan peptide-specific T cell line derived from an HLA-B27 transgenic BALB/c mouse bound significantly stronger to the HLA-B27.Cys67 tetramer than to the HLA-B27.Ser67 tetramer. Modeling studies of the molecular structure suggest the loss of a SH ... {pi} hydrogen bond with the Cys->Ser substitution in the HLA-B27 H chain which reduces the stability of the HLA-B27/peptide complex. These results demonstrate that a solvent-inaccessible residue in the B pocket of HLA-B27 can affect TCR binding in a peptide-dependent fashion.


Related articles in The JI:

IN THIS ISSUE

The JI 2004 173: 6499-6500. [Full Text]  



This article has been cited by other articles:


Home page
J. Immunol.Home page
J. T. Loffredo, J. Sidney, A. T. Bean, D. R. Beal, W. Bardet, A. Wahl, O. E. Hawkins, S. Piaskowski, N. A. Wilson, W. H. Hildebrand, et al.
Two MHC Class I Molecules Associated with Elite Control of Immunodeficiency Virus Replication, Mamu-B*08 and HLA-B*2705, Bind Peptides with Sequence Similarity
J. Immunol., June 15, 2009; 182(12): 7763 - 7775.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.